ADR Biomedical Holdings
3750.TInformation & Communication
Filed as FRACTALE Corporation (2022-06–2022-06), Cytori Cell Research Institute,Inc. (2022-08–2025-11), ADR120S, Inc. (2025-11–2026-06)
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥114m | ¥151m | ¥638m | ¥465m | ¥153m | ¥142m |
| Operating income | −¥473m | −¥237m | ¥450m | −¥4m | ¥4m | −¥13m |
| Ordinary income | −¥475m | −¥2.8bn | −¥587m | −¥196m | ¥212m | ¥93m |
| Total assets | ¥353m | ¥98m | ¥3.3bn | ¥11.9bn | ¥13.0bn | ¥12.8bn |
| Net assets / equity | −¥65m | ¥21m | ¥3.2bn | ¥7.0bn | ¥7.7bn | ¥7.2bn |
| EPS (basic) | ¥14.02 | ¥-354.86 | ¥-421.48 | ¥-82.54 | ¥30.61 | ¥0.97 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 4
| Period | Form | Figures |
|---|---|---|
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 50 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 202 figures · EDINET |
23 more reports are still being processed.
Segments · FY ended 2025-03
| Segment | External sales | Profit |
|---|---|---|
| Medical Asset Managemet | ¥96m | −¥442m |
| Real Asset Management | ¥27m | −¥91m |
| Other segments | — | −¥274m |
| Total | ¥122m | −¥533m |
Segment names from EDINET member IDs; not mapped to a common taxonomy.